Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
SYD-3521 by Byondis for Endometrial Cancer: Likelihood of Approval
SYD-3521 is under clinical development by Byondis and currently in Phase I for Endometrial Cancer. According to GlobalData, Phase I...
SYD-3521 by Byondis for Ovarian Cancer: Likelihood of Approval
SYD-3521 is under clinical development by Byondis and currently in Phase I for Ovarian Cancer. According to GlobalData, Phase I...
SYD-3521 by Byondis for Cervical Cancer: Likelihood of Approval
SYD-3521 is under clinical development by Byondis and currently in Phase I for Cervical Cancer. According to GlobalData, Phase I...
SYD-3521 by Byondis for Esophageal Cancer: Likelihood of Approval
SYD-3521 is under clinical development by Byondis and currently in Phase I for Esophageal Cancer. According to GlobalData, Phase I...
SYD-3521 by Byondis for Non-Small Cell Lung Cancer: Likelihood of Approval
SYD-3521 is under clinical development by Byondis and currently in Phase I for Non-Small Cell Lung Cancer. According to GlobalData,...
SYD-3521 by Byondis for Pancreatic Cancer: Likelihood of Approval
SYD-3521 is under clinical development by Byondis and currently in Phase I for Pancreatic Cancer. According to GlobalData, Phase I...
SYD-3521 by Byondis for Colorectal Cancer: Likelihood of Approval
SYD-3521 is under clinical development by Byondis and currently in Phase I for Colorectal Cancer. According to GlobalData, Phase I...
SYD-3521 by Byondis for Uveal Melanoma: Likelihood of Approval
SYD-3521 is under clinical development by Byondis and currently in Phase I for Uveal Melanoma. According to GlobalData, Phase I...
SYD-3521 by Byondis for Solid Tumor: Likelihood of Approval
SYD-3521 is under clinical development by Byondis and currently in Phase I for Solid Tumor. According to GlobalData, Phase I...